ESMO Congress 2022 - Biognosys

ESMO Congress 2022

Biognosys will be at Esmo ’22 on September 9-13. Find us at booth #433. The team will be eager to explore the unlimited possibilities that proteomics offers for cancer research with you.

Poster Presentations

Prognostic Impact of MARCO and OAS1 Expression in Metastatic Melanoma Patients Treated With Anti-PD1: a Proteomics and Transcriptomics Retrospective Analysis

 

Domenico Mallardo; Christoph Messner; Mariaelena Capone; Jakob Vowinckel; Antonio Sorrentino; Karel Novy; Vito Vanella; Kristina Beeler; Sarah Warren; Paolo Ascierto

PAK4 as a Potential Marker for Poor Response to Immunotherapy in Melanoma Patients

 

Mitchell P. Levesque, Nigel Beaton, Kristina Beeler, Judy Kuo, Harry Nunns, Tobias Treiber, Julia Martinez Gomez, Jakob Vowinckel, and Anna Juncker-Jensen

The team will be eager to explore the unlimited possibilities that proteomics offers for cancer research with you. If you would like to schedule a meeting with our team of experts, please contact us.

 

Conference Page

 

Helpdesk

Access our knowledge base with relevant resources and guiding information.

Contact

    Close banner

    Spectronaut® 16

    The Deepest Proteome
    Coverage Available

    New: Spectronaut® 16

    The Deepest Proteome Coverage Available

    learn more